KalVista Pharmaceuticals logo
KalVista Pharmaceuticals KALV
$ 8.47 4.7%

Quarterly report 2024-Q3
added 12-05-2024

report update icon

KalVista Pharmaceuticals EV/EBITDA Ratio 2011-2024 | KALV

Annual EV/EBITDA Ratio KalVista Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.44 -4.59 -10.7 -1.92 -0.0957 0.857 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.857 -10.7 -3.32